10X Genomics, Bio-Rad reach agreement to resolve patent cases, antitrust counterclaims
MLex Summary: 10X Genomics announced that it entered into a global settlement and patent cross license with Bio-Rad Laboratories, resolving all outstanding litigation and other proceedings between the two companies across...To view the full article, register now.
Already a subscriber? Click here to view full article